These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 27233275)

  • 41. [Preparation and characterization of a monoclonal antibody against human c-Kit].
    Liu HC; Mao CM; Su XY; Ruan Z; Ding QL; Wang XF; Wang HL; Xi XD
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Jul; 25(7):619-22. PubMed ID: 19737481
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antigenic and polypeptide structure of turkey enteric coronaviruses as defined by monoclonal antibodies.
    Dea S; Tijssen P
    J Gen Virol; 1989 Jul; 70 ( Pt 7)():1725-41. PubMed ID: 2472464
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antibodies and Selection of Monoclonal Antibodies.
    Hanack K; Messerschmidt K; Listek M
    Adv Exp Med Biol; 2016; 917():11-22. PubMed ID: 27236550
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Monoclonal antibodies to rat sarcomata. I. Immunization procedures and source of lymphoid cells for hybridoma production.
    North SM; Styles JM; Hobbs SM; Dean CJ
    Immunology; 1982 Nov; 47(3):397-405. PubMed ID: 7129525
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Increased proportion of antigen-specific antibody-producing hybridomas following an in vitro immunization with in vivo immunized mouse spleen cells.
    Enriquez FJ; Bradley-Dunlop D; Joens L
    Hybridoma; 1991 Dec; 10(6):745-51. PubMed ID: 1816073
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Characterisation of mouse monoclonal antibodies targeting linear epitopes on Chikungunya virus E2 glycoprotein.
    Chua CL; Chan YF; Sam IC
    J Virol Methods; 2014 Jan; 195():126-33. PubMed ID: 24134938
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A potent neutralizing IgM mAb targeting the N218 epitope on E2 protein protects against Chikungunya virus pathogenesis.
    Lam S; Nyo M; Phuektes P; Yew CW; Tan YJ; Chu JJ
    MAbs; 2015; 7(6):1178-94. PubMed ID: 26305993
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Passive vaccination with a human monoclonal antibody: generation of antibodies and studies for efficacy in Bacillus anthracis infections.
    vor dem Esche U; Huber M; Zgaga-Griesz A; Grunow R; Beyer W; Hahn U; Bessler WG
    Immunobiology; 2011 Jul; 216(7):847-53. PubMed ID: 21397977
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diagnostic potential of monoclonal antibodies against the capsid protein of chikungunya virus for detection of recent infection.
    Damle RG; Jayaram N; Kulkarni SM; Nigade K; Khutwad K; Gosavi S; Parashar D
    Arch Virol; 2016 Jun; 161(6):1611-22. PubMed ID: 27016930
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Production and characterization of monoclonal antibodies against 17alpha-hydroxyprogesterone.
    Chong H; Cheah SH; Ragavan M; Johgalingam VT
    Hybridoma (Larchmt); 2006 Feb; 25(1):34-40. PubMed ID: 16475880
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Monoclonal antibodies: methods and clinical laboratory applications.
    Nakamura RM
    Clin Physiol Biochem; 1983; 1(2-5):160-72. PubMed ID: 6396016
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Development of human-human hybridoma from anti-Her-2 peptide-producing B cells in immunized NOG mouse.
    Kametani Y; Shiina M; Katano I; Ito R; Ando K; Toyama K; Tsukamoto H; Matsumura T; Saito Y; Ishikawa D; Taki T; Ito M; Imai K; Tokuda Y; Kato S; Tamaoki N; Habu S
    Exp Hematol; 2006 Sep; 34(9):1240-8. PubMed ID: 16939817
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Expression of human-mouse chimeric antibody directed against Chikungunya virus with site-specific integration system].
    Li JM; Chen W; Jia XJ; An XP; Li B; Fan YR; Tong YG
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 May; 21(3):312-5, 318. PubMed ID: 15862148
    [TBL] [Abstract][Full Text] [Related]  

  • 54. High-resolution analysis of the B cell repertoire before and after polyethylene glycol fusion reveals preferential fusion of rare antigen-specific B cells.
    Dubois AR; Buerckert JP; Sinner R; Faison WJ; Molitor AM; Muller CP
    Hum Antibodies; 2016 Jun; 24(1-2):1-15. PubMed ID: 27472868
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synergistic interactions of anti-NS1 monoclonal antibodies protect passively immunized mice from lethal challenge with dengue 2 virus.
    Henchal EA; Henchal LS; Schlesinger JJ
    J Gen Virol; 1988 Aug; 69 ( Pt 8)():2101-7. PubMed ID: 3404125
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Monoclonal antibodies against herpes simplex viruses.
    Scheffer AJ; Koedijk DG; Abee T; Osterhaus AD
    Dev Biol Stand; 1984; 57():269-74. PubMed ID: 6098497
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Generation of rabbit monoclonal antibodies.
    Yam PC; Knight KL
    Methods Mol Biol; 2014; 1131():71-9. PubMed ID: 24515460
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hybridomas producing hemolytic plaques used to study the relationship between monoclonal antibody affinity and the efficiency of plaque inhibition with increasing concentrations of antigen.
    Bankert RB; Mazzaferro D; Mayers GL
    Hybridoma; 1981; 1(1):47-58. PubMed ID: 6765319
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Isolation of single-chain antibody fragments against Venezuelan equine encephalomyelitis virus from two different immune sources.
    Duggan JM; Coates DM; Ulaeto DO
    Viral Immunol; 2001; 14(3):263-73. PubMed ID: 11572636
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Chikungunya virus envelope-specific human monoclonal antibodies with broad neutralization potency.
    Warter L; Lee CY; Thiagarajan R; Grandadam M; Lebecque S; Lin RT; Bertin-Maghit S; Ng LF; Abastado JP; Desprès P; Wang CI; Nardin A
    J Immunol; 2011 Mar; 186(5):3258-64. PubMed ID: 21278338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.